- Home
- SPRU vs FGEN Comparison
SPRU vs FGEN Comparison
Compare SPRU & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- FGEN
- Stock Information
- Founded
- SPRU 2008
- FGEN 1993
- Country
- SPRU United States
- FGEN United States
- Employees
- SPRU N/A
- FGEN N/A
- Industry
- SPRU Auto Parts:O.E.M.
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- FGEN Health Care
- Exchange
- SPRU Nasdaq
- FGEN Nasdaq
- Market Cap
- SPRU 34.9M
- FGEN 33.5M
- IPO Year
- SPRU N/A
- FGEN 2014
- Fundamental
- Price
- SPRU $1.55
- FGEN $8.71
- Analyst Decision
- SPRU
- FGEN Strong Buy
- Analyst Count
- SPRU 0
- FGEN 2
- Target Price
- SPRU N/A
- FGEN $146.50
- AVG Volume (30 Days)
- SPRU 3.8M
- FGEN 30.1K
- Earning Date
- SPRU 08-11-2025
- FGEN 08-11-2025
- Dividend Yield
- SPRU N/A
- FGEN N/A
- EPS Growth
- SPRU N/A
- FGEN N/A
- EPS
- SPRU N/A
- FGEN N/A
- Revenue
- SPRU $87,638,000.00
- FGEN $6,996,000.00
- Revenue This Year
- SPRU $2.12
- FGEN N/A
- Revenue Next Year
- SPRU N/A
- FGEN N/A
- P/E Ratio
- SPRU N/A
- FGEN N/A
- Revenue Growth
- SPRU 9.48
- FGEN N/A
- 52 Week Low
- SPRU $1.13
- FGEN $4.50
- 52 Week High
- SPRU $3.35
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- SPRU 56.10
- FGEN 69.92
- Support Level
- SPRU $1.13
- FGEN $6.72
- Resistance Level
- SPRU $1.32
- FGEN $7.56
- Average True Range (ATR)
- SPRU 0.13
- FGEN 0.45
- MACD
- SPRU 0.03
- FGEN 0.09
- Stochastic Oscillator
- SPRU 67.74
- FGEN 93.87
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.